Merck reaches agreement with US government to expand access to medicines and lower costs for Americans: Rahway, New Jersey Monday, December 22, 2025, 12:00 Hrs [IST] Merck, known ...
Teclistamab (Tecvayli) is an off-the-shelf first-in-class bispecific monoclonal antibody shown in the MajesTEC-1 trial to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback